Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2025.Jun.27

Announcement of 1st Sustainable Development Committee Members

2025.Jun.27

Announcement of 6th Remuneration and Nomination Committee Members

2025.Jun.27

The Company’s Board of Directors nominated Dr. Kung-Yee Liang to serve as the Chairperson of the Board

2025.Jun.27

Announcement of 5th Audit and Risk Management Committee Members

2025.Jun.27

Announcement of 2025 Annual General Shareholders' meeting’s resolution to lift the non-competition restrictions for directors

2025.Jun.27

Announcement of Re-election of directors at the 2025 annual shareholders’ meeting

2025.Jun.27

Announcement of the Company’s important resolutions of the 2025 Annual General Shareholders’ meeting.

2025.Jun.26

Announcement on behalf of OBIGEN that it has submitted the application of its two pivotal phase 3 studies for OBI-858 to TFDA

2025.Jun.23

OBI has submitted the IND application of a Phase I/II human clinical trial for OBI-902 TROP2 ADC to the TFDA

2025.Jun.18

Announcement on behalf of Amaran of important resolutions of the 2025 Annual General Shareholders’ meeting.

News

Latest News

Events

Latest events